These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31821678)

  • 41. [Application of CRISPR-Cas9 gene editing technology in crop breeding].
    Yin W; Chen Z; Huang J; Ye H; Lu T; Lu M; Rao Y
    Sheng Wu Gong Cheng Xue Bao; 2023 Feb; 39(2):399-424. PubMed ID: 36847080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CRISPR/Cas9-Mediated Knockout of MicroRNA-744 Improves Antibody Titer of CHO Production Cell Lines.
    Raab N; Mathias S; Alt K; Handrick R; Fischer S; Schmieder V; Jadhav V; Borth N; Otte K
    Biotechnol J; 2019 May; 14(5):e1800477. PubMed ID: 30802343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of CRISPR-Cas systems in neuroscience.
    Bonnerjee D; Bagh S
    Prog Mol Biol Transl Sci; 2021; 178():231-264. PubMed ID: 33685599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficient Mutagenesis of Marek's Disease Virus-Encoded microRNAs Using a CRISPR/Cas9-Based Gene Editing System.
    Luo J; Teng M; Zai X; Tang N; Zhang Y; Mandviwala A; Reddy VRAP; Baigent S; Yao Y; Nair V
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32325942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CRISPR-Cas9 in genome editing: Its function and medical applications.
    Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
    J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The era of editing plant genomes using CRISPR/Cas: A critical appraisal.
    Bhat MA; Bhat MA; Kumar V; Wani IA; Bashir H; Shah AA; Rahman S; Jan AT
    J Biotechnol; 2020 Dec; 324():34-60. PubMed ID: 32980369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Knock-In Strategy for Editing Human and Zebrafish Mitochondrial DNA Using Mito-CRISPR/Cas9 System.
    Bian WP; Chen YL; Luo JJ; Wang C; Xie SL; Pei DS
    ACS Synth Biol; 2019 Apr; 8(4):621-632. PubMed ID: 30955321
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Applications of ZFN, TALEN and CRISPR/Cas9 techniques in disease modeling and gene therapy].
    Zhao G; Pu J; Tang B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):857-862. PubMed ID: 27984622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multigene editing via CRISPR/Cas9 guided by a single-sgRNA seed in Arabidopsis.
    Yu Z; Chen Q; Chen W; Zhang X; Mei F; Zhang P; Zhao M; Wang X; Shi N; Jackson S; Hong Y
    J Integr Plant Biol; 2018 May; 60(5):376-381. PubMed ID: 29226588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CRISPR/Cas genome editing to optimize pharmacologically active plant natural products.
    Dey A
    Pharmacol Res; 2021 Feb; 164():105359. PubMed ID: 33285226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CRISPR system for genome engineering: the application for autophagy study.
    Cui J; Chew SJL; Shi Y; Gong Z; Shen HM
    BMB Rep; 2017 May; 50(5):247-256. PubMed ID: 28288698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CRISPR-Cas systems: ushering in the new genome editing era.
    Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
    Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Basics of genome editing technology and its application in livestock species.
    Petersen B
    Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Comprehensive Review of Indel Detection Methods for Identification of Zebrafish Knockout Mutants Generated by Genome-Editing Nucleases.
    Carrington B; Bishop K; Sood R
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The CRISPR/Cas system can be used as nuclease for in planta gene targeting and as paired nickases for directed mutagenesis in Arabidopsis resulting in heritable progeny.
    Schiml S; Fauser F; Puchta H
    Plant J; 2014 Dec; 80(6):1139-50. PubMed ID: 25327456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CRISPR/Cas9-Mediated Mutagenesis of Human Pluripotent Stem Cells in Defined Xeno-Free E8 Medium.
    Soh CL; Huangfu D
    Methods Mol Biol; 2017; 1498():57-78. PubMed ID: 27709569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research.
    Aquino-Jarquin G
    Cancer Res; 2017 Dec; 77(24):6812-6817. PubMed ID: 29208606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TEAD4 regulates trophectoderm differentiation upstream of CDX2 in a GATA3-independent manner in the human preimplantation embryo.
    Stamatiadis P; Cosemans G; Boel A; Menten B; De Sutter P; Stoop D; Chuva de Sousa Lopes SM; Lluis F; Coucke P; Heindryckx B
    Hum Reprod; 2022 Jul; 37(8):1760-1773. PubMed ID: 35700449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.